NovaBay Pharmaceuticals Inc (NBY)


NBY on American Stock Exchange

1.34USD
19 Jun 2013
Price Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.34
Open
$1.34
Day's High
$1.34
Day's Low
$1.30
Volume
25,400
Avg. Vol
188,271
52-wk High
$1.76
52-wk Low
$1.05

NBY

Chart for NBY

About

NovaBay Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on addressing the unmet therapeutic needs of the global anti-infective market. The Company’s Aganocide compounds, led by NVC-422, are patented, synthetic molecules with a spectrum of activity against bacteria, viruses and fungi. The Company is... (more)

Overall

Beta: 0.85
Market Cap (Mil.): $50.02
Shares Outstanding (Mil.): 37.33
Dividend: --
Yield (%): --

Financials

  NBY Industry Sector
P/E (TTM): -- 40.13 30.65
EPS (TTM): -0.26 -- --
ROI: -70.73 2.36 18.83
ROE: -96.07 3.58 19.74
Search Stocks

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$460.00
Provider: TheStreet.com Ratings
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks